SCHEMBL23922248

SCHEMBL23922248

CN(C)/C=N\c1ncnc2c1ncn2C1OC(CO)C2OC(C)(C)OC21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KA P42356 2/20 0.66
PI4K2B Q8TCG2 2/20 0.66
PI4K2A Q9BTU6 2/20 0.66
PI4KB Q9UBF8 2/20 0.66
LMNA P02545 2/20 0.49
ALDH1A1 P00352 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
RXFP1 Q9HBX9 2/20 0.47
P2RX1 P51575 1/20 0.46
P2RX3 P56373 1/20 0.46
P2RX4 Q99571 1/20 0.46
GAA P10253 1/20 0.44
OR51E2 Q9H255 1/20 0.43
AMD1 P17707 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
DPP4 P27487 1/20 0.41
MEN1 O00255 1/20 0.41
SLC28A1 O00337 1/20 0.41
MAP3K7 O43318 1/20 0.41
SLC28A2 O43868 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22393148 1.00 PI4KA (0.66) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL22402618 1.00 PI4KA (0.66) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL29703062 1.00 PI4KA (0.66) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL11685537 1.00 PI4KA (0.66) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL26361515 1.00 PI4KA (0.66) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL22393092 0.86 P2RX3 (0.60) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL22393095 0.86 P2RX3 (0.60) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL22393090 0.86 P2RX3 (0.55) PI4KAPI4K2BPI4K2API4KBALDH1A1
SCHEMBL18571712 0.84 PI4KA (0.50) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL9940677 0.82 PI4KA (0.74) PI4KAPI4K2BPI4K2API4KBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11840551-B2 Compositions and methods of modulating the immune response by activating alpha protein kinase 1 SHANGHAI YAO YUAN BIOTECHNOLOGY CO., LTD. (CN) 2023-12-12 US disclosed
US-11149051-B2 Compositions and methods of modulating the immune response by activating alpha protein kinase 1 SHANGHAI YAO YUAN BIOTECHNOLOGY CO., LTD. (CN) 2021-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11149051-B2 Compositions and methods of modulating the immune response by activating alpha protein kinase 1 PHKA1, PHKA2, PRKCA PI4KA 123/4885PI4K2B 194/4885PI4K2A 147/4885
US-11840551-B2 Compositions and methods of modulating the immune response by activating alpha protein kinase 1 PHKA1, PHKA2, PRKCA PI4KA 123/4885PI4K2B 194/4885PI4K2A 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.